Cargando…

Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?

OBJECTIVES: To compare the diagnostic accuracy of a single T2 Dixon sequence to the combination T1+STIR as anatomical sequences used for detecting tumoral bone marrow lesions in whole-body MRI (WB-MRI) examinations. METHODS: Between January 2019 and January 2020, seventy-two consecutive patients (55...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiabai, Ophelye, Van Nieuwenhove, Sandy, Vekemans, Marie-Christiane, Tombal, Bertrand, Peeters, Frank, Wuts, Joris, Triqueneaux, Perrine, Omoumi, Patrick, Kirchgesner, Thomas, Michoux, Nicolas, Lecouvet, Frédéric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755082/
https://www.ncbi.nlm.nih.gov/pubmed/35925384
http://dx.doi.org/10.1007/s00330-022-09007-8
_version_ 1784851349318402048
author Chiabai, Ophelye
Van Nieuwenhove, Sandy
Vekemans, Marie-Christiane
Tombal, Bertrand
Peeters, Frank
Wuts, Joris
Triqueneaux, Perrine
Omoumi, Patrick
Kirchgesner, Thomas
Michoux, Nicolas
Lecouvet, Frédéric E.
author_facet Chiabai, Ophelye
Van Nieuwenhove, Sandy
Vekemans, Marie-Christiane
Tombal, Bertrand
Peeters, Frank
Wuts, Joris
Triqueneaux, Perrine
Omoumi, Patrick
Kirchgesner, Thomas
Michoux, Nicolas
Lecouvet, Frédéric E.
author_sort Chiabai, Ophelye
collection PubMed
description OBJECTIVES: To compare the diagnostic accuracy of a single T2 Dixon sequence to the combination T1+STIR as anatomical sequences used for detecting tumoral bone marrow lesions in whole-body MRI (WB-MRI) examinations. METHODS: Between January 2019 and January 2020, seventy-two consecutive patients (55 men, 17 women, median age = 66 years) with solid (prostate, breast, neuroendocrine) cancers at high risk of metastasis or proven multiple myeloma (MM) prospectively underwent a WB-MRI examination including coronal T1, STIR, T2 Dixon and axial diffusion-weighted imaging sequences. Two radiologists independently assessed the combination of T1+STIR sequences and the fat+water reconstructions from the T2 Dixon sequence. The reference standard was established by consensus reading of WB-MRI and concurrent imaging available at baseline and at 6 months. Repeatability and reproducibility of MRI scores (presence and semi-quantitative count of lesions), image quality (SNR: signal-to-noise, CNR: contrast-to-noise, CRR: contrast-to-reference ratios), and diagnostic characteristics (Se: sensitivity, Sp: specificity, Acc: accuracy) were assessed per-skeletal region and per-patient. RESULTS: Repeatability and reproducibility were at least good regardless of the score, region, and protocol (0.67 ≤ AC1 ≤ 0.98). CRR was higher on T2 Dixon fat compared to T1 (p < 0.0001) and on T2 Dixon water compared to STIR (p = 0.0128). In the per-patient analysis, Acc of the T2 Dixon fat+water was higher than that of T1+STIR for the senior reader (Acc = +0.027 [+0.025; +0.029], p < 0.0001) and lower for the junior reader (Acc = −0.029 [−0.031; −0.027], p < 0.0001). CONCLUSIONS: A single T2 Dixon sequence with fat+water reconstructions offers similar reproducibility and diagnostic accuracy as the recommended combination of T1+STIR sequences and can be used for skeletal screening in oncology, allowing significant time-saving. KEY POINTS: • Replacement of the standard anatomic T1 + STIR WB-MRI protocol by a single T2 Dixon sequence drastically shortens the examination time without loss of diagnostic accuracy. • A protocol based on fat + water reconstructions from a single T2 Dixon sequence offers similar inter-reader agreement and a higher contrast-to-reference ratio for detecting lesions compared to the standard T1 + STIR protocol. • Differences in the accuracy between the two protocols are marginal (+ 3% in favor of the T2 Dixon with the senior reader; −3% against the T2 Dixon with the junior reader). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09007-8.
format Online
Article
Text
id pubmed-9755082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97550822022-12-17 Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma? Chiabai, Ophelye Van Nieuwenhove, Sandy Vekemans, Marie-Christiane Tombal, Bertrand Peeters, Frank Wuts, Joris Triqueneaux, Perrine Omoumi, Patrick Kirchgesner, Thomas Michoux, Nicolas Lecouvet, Frédéric E. Eur Radiol Oncology OBJECTIVES: To compare the diagnostic accuracy of a single T2 Dixon sequence to the combination T1+STIR as anatomical sequences used for detecting tumoral bone marrow lesions in whole-body MRI (WB-MRI) examinations. METHODS: Between January 2019 and January 2020, seventy-two consecutive patients (55 men, 17 women, median age = 66 years) with solid (prostate, breast, neuroendocrine) cancers at high risk of metastasis or proven multiple myeloma (MM) prospectively underwent a WB-MRI examination including coronal T1, STIR, T2 Dixon and axial diffusion-weighted imaging sequences. Two radiologists independently assessed the combination of T1+STIR sequences and the fat+water reconstructions from the T2 Dixon sequence. The reference standard was established by consensus reading of WB-MRI and concurrent imaging available at baseline and at 6 months. Repeatability and reproducibility of MRI scores (presence and semi-quantitative count of lesions), image quality (SNR: signal-to-noise, CNR: contrast-to-noise, CRR: contrast-to-reference ratios), and diagnostic characteristics (Se: sensitivity, Sp: specificity, Acc: accuracy) were assessed per-skeletal region and per-patient. RESULTS: Repeatability and reproducibility were at least good regardless of the score, region, and protocol (0.67 ≤ AC1 ≤ 0.98). CRR was higher on T2 Dixon fat compared to T1 (p < 0.0001) and on T2 Dixon water compared to STIR (p = 0.0128). In the per-patient analysis, Acc of the T2 Dixon fat+water was higher than that of T1+STIR for the senior reader (Acc = +0.027 [+0.025; +0.029], p < 0.0001) and lower for the junior reader (Acc = −0.029 [−0.031; −0.027], p < 0.0001). CONCLUSIONS: A single T2 Dixon sequence with fat+water reconstructions offers similar reproducibility and diagnostic accuracy as the recommended combination of T1+STIR sequences and can be used for skeletal screening in oncology, allowing significant time-saving. KEY POINTS: • Replacement of the standard anatomic T1 + STIR WB-MRI protocol by a single T2 Dixon sequence drastically shortens the examination time without loss of diagnostic accuracy. • A protocol based on fat + water reconstructions from a single T2 Dixon sequence offers similar inter-reader agreement and a higher contrast-to-reference ratio for detecting lesions compared to the standard T1 + STIR protocol. • Differences in the accuracy between the two protocols are marginal (+ 3% in favor of the T2 Dixon with the senior reader; −3% against the T2 Dixon with the junior reader). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09007-8. Springer Berlin Heidelberg 2022-08-04 2023 /pmc/articles/PMC9755082/ /pubmed/35925384 http://dx.doi.org/10.1007/s00330-022-09007-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Oncology
Chiabai, Ophelye
Van Nieuwenhove, Sandy
Vekemans, Marie-Christiane
Tombal, Bertrand
Peeters, Frank
Wuts, Joris
Triqueneaux, Perrine
Omoumi, Patrick
Kirchgesner, Thomas
Michoux, Nicolas
Lecouvet, Frédéric E.
Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title_full Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title_fullStr Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title_full_unstemmed Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title_short Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
title_sort whole-body mri in oncology: can a single anatomic t2 dixon sequence replace the combination of t1 and stir sequences to detect skeletal metastasis and myeloma?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755082/
https://www.ncbi.nlm.nih.gov/pubmed/35925384
http://dx.doi.org/10.1007/s00330-022-09007-8
work_keys_str_mv AT chiabaiophelye wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT vannieuwenhovesandy wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT vekemansmariechristiane wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT tombalbertrand wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT peetersfrank wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT wutsjoris wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT triqueneauxperrine wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT omoumipatrick wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT kirchgesnerthomas wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT michouxnicolas wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma
AT lecouvetfrederice wholebodymriinoncologycanasingleanatomict2dixonsequencereplacethecombinationoft1andstirsequencestodetectskeletalmetastasisandmyeloma